Nomura Holdings’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.07M | Sell |
16,730
-130,531
| -89% | -$24.1M | 0.01% | 793 |
|
|
2025
Q4 | $25.9M | Buy |
147,261
+24,359
| +20% | +$3.98M | 0.03% | 261 |
|
|
2025
Q3 | $17.2M | Buy |
122,902
+2,087
| +2% | +$282K | 0.03% | 353 |
|
|
2025
Q2 | $15.2M | Sell |
120,815
-92,955
| -43% | -$11.6M | 0.03% | 313 |
|
|
2025
Q1 | $29.3M | Sell |
213,770
-5,110
| -2% | -$731K | 0.05% | 227 |
|
|
2024
Q4 | $33.5M | Buy |
218,880
+209,613
| +2,262% | +$35.4M | 0.05% | 208 |
|
|
2024
Q3 | $1.8M | Buy |
+9,267
| New | +$1.94M | ﹤0.01% | 973 |
|
|
2024
Q1 | – | Sell |
-2,924
| Closed | -$685K | – | 1644 |
|
|
2023
Q4 | $757K | Buy |
+2,924
| New | +$718K | ﹤0.01% | 1256 |
|
|
2023
Q3 | – | Sell |
-2,769
| Closed | -$789K | – | 1384 |
|
|
2023
Q2 | $789K | Buy |
+2,769
| New | +$824K | ﹤0.01% | 959 |
|
|
2023
Q1 | – | Sell |
-18,505
| Closed | -$5.05M | – | 1467 |
|
|
2022
Q4 | $5.05M | Buy |
18,505
+777
| +4% | +$219K | 0.02% | 493 |
|
|
2022
Q3 | $4.68M | Buy |
17,728
+2,461
| +16% | +$523K | 0.02% | 575 |
|
|
2022
Q2 | $3.28M | Sell |
15,267
-2,604
| -15% | -$532K | 0.01% | 658 |
|
|
2022
Q1 | $3.84M | Sell |
17,871
-15,356
| -46% | -$3.34M | 0.01% | 708 |
|
|
2021
Q4 | $7.99M | Buy |
33,227
+19,793
| +147% | +$5.09M | 0.02% | 556 |
|
|
2021
Q3 | $3.9M | Sell |
13,434
-31,611
| -70% | -$10.4M | 0.01% | 708 |
|
|
2021
Q2 | $16.1M | Buy |
45,045
+44,689
| +12,553% | +$13.5M | 0.04% | 250 |
|
|
2021
Q1 | $100K | Sell |
356
-33,590
| -99% | -$9.06M | ﹤0.01% | 1705 |
|
|
2020
Q4 | $8.31M | Buy |
33,946
+32,148
| +1,788% | +$8.29M | 0.01% | 473 |
|
|
2020
Q3 | $507K | Sell |
1,798
-53,592
| -97% | -$14.9M | ﹤0.01% | 1000 |
|
|
2020
Q2 | $15M | Buy |
55,390
+48,933
| +758% | +$14.7M | 0.05% | 219 |
|
|
2020
Q1 | $2.02M | Sell |
6,457
-69,197
| -91% | -$21M | 0.01% | 461 |
|
|
2019
Q4 | $21.9M | Sell |
75,654
-140,333
| -65% | -$38.9M | 0.08% | 184 |
|
|
2019
Q3 | $49.5M | Buy |
215,987
+158,593
| +276% | +$36.9M | 0.19% | 92 |
|
|
2019
Q2 | $13.5M | Buy |
57,394
+18,778
| +49% | +$4.34M | 0.06% | 262 |
|
|
2019
Q1 | $8.91M | Buy |
38,616
+13,735
| +55% | +$4.32M | 0.04% | 326 |
|
|
2018
Q4 | $7.59M | Sell |
24,881
-41,492
| -63% | -$13.2M | 0.03% | 386 |
|
|
2018
Q3 | $23.3M | Buy |
66,373
+49,412
| +291% | +$17M | 0.08% | 209 |
|
|
2018
Q2 | $4.92M | Sell |
16,961
-3,733
| -18% | -$1.05M | 0.02% | 510 |
|
|
2018
Q1 | $5.68K | Sell |
20,694
-5,148
| -20% | -$1.6M | 0.01% | 534 |
|
|
2017
Q4 | $8.24M | Buy |
25,842
+13,514
| +110% | +$4.34M | 0.01% | 499 |
|
|
2017
Q3 | $3.87M | Sell |
12,328
-5,230
| -30% | -$1.55M | 0.01% | 622 |
|
|
2017
Q2 | $4.72M | Sell |
17,558
-18,227
| -51% | -$4.82M | 0.01% | 562 |
|
|
2017
Q1 | $9.79M | Sell |
35,785
-18,739
| -34% | -$5.3M | 0.03% | 311 |
|
|
2016
Q4 | $15.6M | Buy |
54,524
+53,438
| +4,921% | +$15.8M | 0.04% | 265 |
|
|
2016
Q3 | $337K | Buy |
+1,086
| New | +$322K | ﹤0.01% | 971 |
|
|
2016
Q2 | – | Sell |
-1,893
| Closed | -$499K | – | 1256 |
|
|
2016
Q1 | $487K | Sell |
1,893
-20,625
| -92% | -$5.45M | ﹤0.01% | 888 |
|
|
2015
Q4 | $6.9M | Sell |
22,518
-4,460
| -17% | -$1.28M | 0.02% | 327 |
|
|
2015
Q3 | $7.9M | Buy |
26,978
+6,240
| +30% | +$2.06M | 0.03% | 277 |
|
|
2015
Q2 | $8.31M | Buy |
20,738
+18,793
| +966% | +$7.54M | 0.02% | 295 |
|
|
2015
Q1 | $801K | Sell |
1,945
-18,276
| -90% | -$7.2M | ﹤0.01% | 890 |
|
|
2014
Q4 | $6.85M | Sell |
20,221
-3,384
| -14% | -$1.09M | 0.02% | 489 |
|
|
2014
Q3 | $7.79M | Buy |
23,605
+14,224
| +152% | +$4.69M | 0.02% | 520 |
|
|
2014
Q2 | $3.01M | Sell |
9,381
-39,867
| -81% | -$12M | ﹤0.01% | 924 |
|
|
2014
Q1 | $15.4M | Buy |
49,248
+5,806
| +13% | +$1.84M | ﹤0.01% | 352 |
|
|
2013
Q4 | $12.1M | Buy |
43,442
+4,981
| +13% | +$1.29M | 0.06% | 199 |
|
|
2013
Q3 | $9.17M | Buy |
38,461
+15,340
| +66% | +$3.43M | 0.06% | 283 |
|
|
2013
Q2 | $5M | Buy |
+23,121
| New | +$4.94M | 0.04% | 319 |
|
Other funds holding BIIB
VCM
VPM
Nomura Holdings's BIIB Position: Q1 2026 in Review
Nomura Holdings reduced its Biogen (BIIB) stake by 89% in Q1 2026, selling an estimated $24.1M and leaving 16,730 shares worth $3.07M. The position accounts for 0.01% of the portfolio, ranked #793.
Nomura Holdings first reported a position in BIIB in Q2 2013 and has held it in 47 quarters since. The position peaked at $49.5M in Q3 2019. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Nomura Holdings held 16,730 shares of Biogen worth $3.07M as of Q1 2026.
- Nomura Holdings sold 130,531 Biogen shares in Q1 2026, an estimated $24.1M.
- Biogen made up 0.01% of Nomura Holdings's portfolio in Q1 2026, its #793 holding.
- Nomura Holdings first reported a position in Biogen in Q2 2013 and has held it in 47 quarters since.
- Nomura Holdings's Biogen position peaked at $49.5M in Q3 2019.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.